What is Organs-on-chips:
The Organs-on-a-Chip technology is a new alternative way to screen drug candidates in a very early stage for efficacy and toxicity. The technology enables researchers to cultivate human cells representing organs under physiological conditions.
Organs-on-chips are a multi-channel 3-D microfluidic cell culture chit that fosters the actions, mechanics and physiological response of entire organs and organ system.
The Organs-on-chips market is anticipated to grow in the forecast, owing to the factors such as wave in applications of OOC devices in the healthcare sector, increase in demand for organ-on-chip in drug screening, rise in in-demand OOCs for lung & Kidney based organ culture, improving R&D pertaining to OOCs and increase in research activities. Nevertheless, high cost of OOC devices may restrict the market growth during the forecast period.
Future of Organs on Chips:
The "Global Organs-on-chips Market Analysis to 2027" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of Organs-on-chips market with detailed market segmentation by type, offerings, application end user and geography. The global Organs-on-chips market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Organs-on-chips/lung stent market players and offers key trends and opportunities in the market.
The global Organs-on-chips market is segmented on the basis of Type, Offerings, Application and End User. Based on Type the market is segmented as Liver-on-chip, Kidney-on-chip, Lung-on-chip, Heart-on-chip and Other Organs. Based on offering the market is segmented into Product and Services. Based on Application the market is segmented as Physiological Model Development, Drug Discovery and Toxicology Research. Based on End User the market is segmented into Pharmaceuticals and Biotechnology Companies, Academic and Research Institutes, Cosmetic Industry and Other End Users.
The key players operating in the Organs-on-chips industry include, NeuroPace, Inc., Medtronic, Boston Scientific Corporation, Nevro Corp., ALEVA NEUROTHERAPEUTICS SA, NEUROCONTROL, TERUMO CORPORATION, ABIOMED, Edwards Lifesciences Corporation, Cochlear Ltd. and others.